BP8-30503-72086 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Dose 1 — Pfizer-BioNTech
2021-01-04
Registered in v-safe
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-15
Dose 2 — Pfizer-BioNTech
2021-01-22
Survey response — day 7, dose 2
MedDRA: Chills, Headache, Pyrexia — Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activities

Free text: Fever headache and chills first 36 hrs after 2nd dose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-25
Dose 3 — Pfizer-BioNTech
2021-09-29
Survey response — days 1–6 daily, dose 3
MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Symptoms occurred in first 24-36 hours only

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-15	Pfizer-BioNTech
3	2021-09-25	Pfizer-BioNTech	No

Free text

Release 2 — day 7, dose 2

2021-01-22

Systemic reaction (other): Fever headache and chills first 36 hrs after 2nd dose

Release 9 — days 1–6 daily, dose 3

2021-09-29

Systemic reaction (other): Symptoms occurred in first 24-36 hours only

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Adverse reaction	·	·	✓
SRO	Chills	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Pyrexia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release